Close Menu

NEW YORK (GenomeWeb) – Oregon Health & Science University (OHSU) and Swedish diagnostics firm Immunovia today announced a collaboration on a diagnostic test for the early detection of pancreatic cancer.

Under the terms of the agreement, the partners will confirm, validate, and commercialize the Immray PanCan-d blood test. A retrospective study using patients samples from OHSU's Brenden-Colson Center for Pancreatic Care will seek to confirm earlier results from studies in Europe and China with a US population. The partners will also explore biomarkers for other cancer types.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.